B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
Journal
Frontiers in oncology
Journal Volume
12
Date Issued
2022-06
Author(s)
Hsu, Chia-Lang
Wu, I-Chen
Lin, Chen-Yuan
Lien, Ming-Yu
Abstract
B cells and B cell-related gene signatures in the tumor microenvironment (TME) are associated with the efficacy of anti-programmed cell death-1 (anti-PD-1) therapy in several cancer types, but not known for esophageal squamous cell carcinoma (ESCC).
Subjects
B cell; efficacy; esophageal squamous cell carcinoma; immune checkpoint inhibitor; prognosis
SDGs
Publisher
FRONTIERS MEDIA SA
Type
journal article